INICIATIVAS COMERCIALES GLOBALBIOTICS SL
Company details
- Active NIF/CIF: B84459676
-
-
-
-
Address: Calle Fuencarral, 139, 28010 Madrid, Madrid, España See in map
-
-
Featured products:
More information on INICIATIVAS COMERCIALES GLOBALBIOTICS SL
-
05/11/2007 | BORME act no.: 950438 | Register: MADRIDDepósito de cuentas anuales (Octubre de 2007)
-
22/08/2006 | BORME act no.: 242196 | Register: MADRIDDepósito de cuentas anuales (Agosto de 2006)
-
29/12/2005 | BORME act no.: 553508 | Register: MADRIDConstitución
-
29/12/2005 | BORME act no.: 553508 | Register: MADRIDDeclaración de unipersonalidad
-
29/12/2005 | BORME act no.: 553508 | Register: MADRIDNombramientos
Other information
The CIF of INICIATIVAS COMERCIALES GLOBALBIOTICS SL is B84459676 and its current status in the market is active. The company operates in the economic sector corresponding to the CNAE 4646 - Comercio al por mayor de productos farmacéuticos. As for its SIC, it is 5946 - Equipo de radio y televisión para telecomunicaciones.
INICIATIVAS COMERCIALES GLOBALBIOTICS SL employs approximately Between 10 and 49 employees and generates annual revenues of less than 2 million euros. The company is registered in the Mercantile Registry of Madrid and has a total of 2 registered positions. Its most recent announcement in the Borme is from 05/11/2007, while its last filing of ordinary annual accounts corresponds to the year -.
To obtain contact information for INICIATIVAS COMERCIALES GLOBALBIOTICS SL, such as phone number, postal address, or website, please refer to the Company Data section.
If you would like more details about INICIATIVAS COMERCIALES GLOBALBIOTICS SL, you can review one of our available financial reports, the company's annual accounts, or check its default incidents in the RAI delinquency register.
All the financial, commercial, and legal information we provide about INICIATIVAS COMERCIALES GLOBALBIOTICS SL comes from official sources and is regularly updated.
Do you want to know more about INICIATIVAS COMERCIALES GLOBALBIOTICS SL??
Find out more about this company by consulting these reports: